Equinox Gold (CVE:EQX – Get Free Report) had its target price decreased by equities researchers at Scotiabank from C$7.00 to C$6.75 in a research report issued on Monday, BayStreet.CA reports. The brokerage currently has a “sector perform” rating on the stock. Scotiabank’s price objective would indicate a potential downside of 14.34% from the company’s previous close.
A number of other research analysts also recently issued reports on EQX. CIBC boosted their price objective on Equinox Gold from C$6.80 to C$9.25 in a research note on Monday, April 15th. TD Securities reduced their price objective on shares of Equinox Gold from C$8.50 to C$8.00 and set a “buy” rating for the company in a research note on Friday, February 23rd. National Bankshares lowered their target price on shares of Equinox Gold from C$11.50 to C$10.50 in a research note on Friday, April 19th. Haywood Securities cut their price target on Equinox Gold from C$11.50 to C$10.50 in a research note on Monday, February 26th. Finally, Canaccord Genuity Group boosted their price objective on Equinox Gold from C$11.50 to C$11.75 in a research report on Tuesday, April 23rd. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of C$9.03.
Read Our Latest Research Report on EQX
Equinox Gold Price Performance
Equinox Gold Company Profile
Equinox Gold Corp. engages in the acquisition, exploration, and development of mineral deposits. The company's principal properties include the Aurizona project covering a total land package of approximately 223,160 hectares located in Maranhão State, Brazil; and the Castle Mountain property situated in California, the United States.
See Also
- Five stocks we like better than Equinox Gold
- How to invest in blue chip stocks
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the Dogs of the Dow Strategy? Overview and Examples
- Hilton Demonstrates Asset Light is Right for Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Equinox Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equinox Gold and related companies with MarketBeat.com's FREE daily email newsletter.